nodes	percent_of_prediction	percent_of_DWPC	metapath
Tropicamide—Rash erythematous—Nevirapine—acquired immunodeficiency syndrome	0.0191	0.0205	CcSEcCtD
Tropicamide—Cerebration impaired—Efavirenz—acquired immunodeficiency syndrome	0.0184	0.0197	CcSEcCtD
Tropicamide—Cerebration impaired—Delavirdine—acquired immunodeficiency syndrome	0.0176	0.0188	CcSEcCtD
Tropicamide—Rash erythematous—Zidovudine—acquired immunodeficiency syndrome	0.0161	0.0172	CcSEcCtD
Tropicamide—Disturbance in attention—Efavirenz—acquired immunodeficiency syndrome	0.0125	0.0134	CcSEcCtD
Tropicamide—Pallor—Delavirdine—acquired immunodeficiency syndrome	0.0125	0.0134	CcSEcCtD
Tropicamide—Mental disability—Stavudine—acquired immunodeficiency syndrome	0.0123	0.0131	CcSEcCtD
Tropicamide—Disturbance in attention—Delavirdine—acquired immunodeficiency syndrome	0.0119	0.0128	CcSEcCtD
Tropicamide—Photophobia—Zidovudine—acquired immunodeficiency syndrome	0.0115	0.0124	CcSEcCtD
Tropicamide—Disturbance in attention—Ritonavir—acquired immunodeficiency syndrome	0.011	0.0118	CcSEcCtD
Tropicamide—Photophobia—Delavirdine—acquired immunodeficiency syndrome	0.00971	0.0104	CcSEcCtD
Tropicamide—Mental disability—Efavirenz—acquired immunodeficiency syndrome	0.00938	0.01	CcSEcCtD
Tropicamide—Photophobia—Ritonavir—acquired immunodeficiency syndrome	0.00898	0.00961	CcSEcCtD
Tropicamide—Mental disability—Delavirdine—acquired immunodeficiency syndrome	0.00897	0.00961	CcSEcCtD
Tropicamide—Bronchospasm—Nelfinavir—acquired immunodeficiency syndrome	0.00876	0.00938	CcSEcCtD
Tropicamide—Dysuria—Stavudine—acquired immunodeficiency syndrome	0.0083	0.00889	CcSEcCtD
Tropicamide—Mental disability—Ritonavir—acquired immunodeficiency syndrome	0.0083	0.00889	CcSEcCtD
Tropicamide—Photophobia—Lamivudine—acquired immunodeficiency syndrome	0.00824	0.00883	CcSEcCtD
Tropicamide—Thirst—Delavirdine—acquired immunodeficiency syndrome	0.00789	0.00845	CcSEcCtD
Tropicamide—Dysphagia—Zidovudine—acquired immunodeficiency syndrome	0.00772	0.00826	CcSEcCtD
Tropicamide—Psychotic disorder—Efavirenz—acquired immunodeficiency syndrome	0.00766	0.0082	CcSEcCtD
Tropicamide—Sweating increased—Zidovudine—acquired immunodeficiency syndrome	0.00752	0.00805	CcSEcCtD
Tropicamide—Thirst—Ritonavir—acquired immunodeficiency syndrome	0.00729	0.00781	CcSEcCtD
Tropicamide—Dysuria—Zidovudine—acquired immunodeficiency syndrome	0.00721	0.00773	CcSEcCtD
Tropicamide—Rhinitis—Nelfinavir—acquired immunodeficiency syndrome	0.00715	0.00765	CcSEcCtD
Tropicamide—Rhinitis—Stavudine—acquired immunodeficiency syndrome	0.00712	0.00763	CcSEcCtD
Tropicamide—Thirst—Saquinavir—acquired immunodeficiency syndrome	0.00702	0.00752	CcSEcCtD
Tropicamide—Dysuria—Indinavir—acquired immunodeficiency syndrome	0.00671	0.00719	CcSEcCtD
Tropicamide—Thirst—Lamivudine—acquired immunodeficiency syndrome	0.0067	0.00717	CcSEcCtD
Tropicamide—Sweating increased—Efavirenz—acquired immunodeficiency syndrome	0.0066	0.00707	CcSEcCtD
Tropicamide—Psychotic disorder—Saquinavir—acquired immunodeficiency syndrome	0.00652	0.00699	CcSEcCtD
Tropicamide—Dysphagia—Delavirdine—acquired immunodeficiency syndrome	0.00649	0.00695	CcSEcCtD
Tropicamide—Sweating increased—Delavirdine—acquired immunodeficiency syndrome	0.00632	0.00677	CcSEcCtD
Tropicamide—Rhinitis—Zidovudine—acquired immunodeficiency syndrome	0.00619	0.00663	CcSEcCtD
Tropicamide—Drowsiness—Efavirenz—acquired immunodeficiency syndrome	0.00604	0.00647	CcSEcCtD
Tropicamide—Dysphagia—Ritonavir—acquired immunodeficiency syndrome	0.006	0.00642	CcSEcCtD
Tropicamide—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00581	0.00623	CcSEcCtD
Tropicamide—Dysphagia—Saquinavir—acquired immunodeficiency syndrome	0.00577	0.00618	CcSEcCtD
Tropicamide—Sweating increased—Saquinavir—acquired immunodeficiency syndrome	0.00562	0.00602	CcSEcCtD
Tropicamide—Dysuria—Ritonavir—acquired immunodeficiency syndrome	0.00561	0.00601	CcSEcCtD
Tropicamide—Dysphagia—Lamivudine—acquired immunodeficiency syndrome	0.00551	0.0059	CcSEcCtD
Tropicamide—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.0055	0.00589	CcSEcCtD
Tropicamide—Rhinitis—Efavirenz—acquired immunodeficiency syndrome	0.00544	0.00583	CcSEcCtD
Tropicamide—Sweating increased—Lamivudine—acquired immunodeficiency syndrome	0.00537	0.00575	CcSEcCtD
Tropicamide—Flushing—Indinavir—acquired immunodeficiency syndrome	0.00533	0.00571	CcSEcCtD
Tropicamide—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.00523	0.0056	CcSEcCtD
Tropicamide—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00523	0.0056	CcSEcCtD
Tropicamide—Rhinitis—Delavirdine—acquired immunodeficiency syndrome	0.00521	0.00557	CcSEcCtD
Tropicamide—Dysuria—Lamivudine—acquired immunodeficiency syndrome	0.00515	0.00552	CcSEcCtD
Tropicamide—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00506	0.00542	CcSEcCtD
Tropicamide—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.00504	0.00539	CcSEcCtD
Tropicamide—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00497	0.00533	CcSEcCtD
Tropicamide—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00497	0.00533	CcSEcCtD
Tropicamide—Pain—Didanosine—acquired immunodeficiency syndrome	0.00497	0.00532	CcSEcCtD
Tropicamide—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.0049	0.00524	CcSEcCtD
Tropicamide—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00488	0.00523	CcSEcCtD
Tropicamide—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.00485	0.00519	CcSEcCtD
Tropicamide—Rhinitis—Ritonavir—acquired immunodeficiency syndrome	0.00481	0.00515	CcSEcCtD
Tropicamide—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.00471	0.00505	CcSEcCtD
Tropicamide—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00465	0.00498	CcSEcCtD
Tropicamide—Rhinitis—Saquinavir—acquired immunodeficiency syndrome	0.00463	0.00496	CcSEcCtD
Tropicamide—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00458	0.0049	CcSEcCtD
Tropicamide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00451	0.00483	CcSEcCtD
Tropicamide—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.00451	0.00483	CcSEcCtD
Tropicamide—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.0045	0.00482	CcSEcCtD
Tropicamide—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00449	0.00481	CcSEcCtD
Tropicamide—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00447	0.00479	CcSEcCtD
Tropicamide—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.00446	0.00477	CcSEcCtD
Tropicamide—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00445	0.00477	CcSEcCtD
Tropicamide—Rhinitis—Lamivudine—acquired immunodeficiency syndrome	0.00442	0.00473	CcSEcCtD
Tropicamide—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.00442	0.00473	CcSEcCtD
Tropicamide—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00439	0.0047	CcSEcCtD
Tropicamide—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00439	0.0047	CcSEcCtD
Tropicamide—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00435	0.00466	CcSEcCtD
Tropicamide—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00433	0.00464	CcSEcCtD
Tropicamide—Pain—Stavudine—acquired immunodeficiency syndrome	0.00432	0.00462	CcSEcCtD
Tropicamide—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00432	0.00462	CcSEcCtD
Tropicamide—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00429	0.00459	CcSEcCtD
Tropicamide—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00428	0.00459	CcSEcCtD
Tropicamide—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00426	0.00456	CcSEcCtD
Tropicamide—Pain—Abacavir—acquired immunodeficiency syndrome	0.00425	0.00455	CcSEcCtD
Tropicamide—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00424	0.00454	CcSEcCtD
Tropicamide—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00417	0.00447	CcSEcCtD
Tropicamide—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00417	0.00447	CcSEcCtD
Tropicamide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00411	0.00441	CcSEcCtD
Tropicamide—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00408	0.00437	CcSEcCtD
Tropicamide—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00408	0.00437	CcSEcCtD
Tropicamide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00406	0.00434	CcSEcCtD
Tropicamide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.004	0.00428	CcSEcCtD
Tropicamide—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00399	0.00428	CcSEcCtD
Tropicamide—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00394	0.00422	CcSEcCtD
Tropicamide—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00394	0.00422	CcSEcCtD
Tropicamide—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.0039	0.00418	CcSEcCtD
Tropicamide—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00385	0.00413	CcSEcCtD
Tropicamide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00379	0.00406	CcSEcCtD
Tropicamide—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00378	0.00405	CcSEcCtD
Tropicamide—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00376	0.00403	CcSEcCtD
Tropicamide—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00375	0.00402	CcSEcCtD
Tropicamide—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00375	0.00402	CcSEcCtD
Tropicamide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00375	0.00402	CcSEcCtD
Tropicamide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00373	0.004	CcSEcCtD
Tropicamide—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00373	0.00399	CcSEcCtD
Tropicamide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00372	0.00398	CcSEcCtD
Tropicamide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.0037	0.00396	CcSEcCtD
Tropicamide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.0037	0.00396	CcSEcCtD
Tropicamide—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00369	0.00396	CcSEcCtD
Tropicamide—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00369	0.00395	CcSEcCtD
Tropicamide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00366	0.00392	CcSEcCtD
Tropicamide—Headache—Didanosine—acquired immunodeficiency syndrome	0.00364	0.0039	CcSEcCtD
Tropicamide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00363	0.00389	CcSEcCtD
Tropicamide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00363	0.00388	CcSEcCtD
Tropicamide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00362	0.00388	CcSEcCtD
Tropicamide—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.0036	0.00386	CcSEcCtD
Tropicamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00358	0.00384	CcSEcCtD
Tropicamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00357	0.00382	CcSEcCtD
Tropicamide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00357	0.00382	CcSEcCtD
Tropicamide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00357	0.00382	CcSEcCtD
Tropicamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00352	0.00377	CcSEcCtD
Tropicamide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00352	0.00377	CcSEcCtD
Tropicamide—Pain—Indinavir—acquired immunodeficiency syndrome	0.00349	0.00374	CcSEcCtD
Tropicamide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00349	0.00374	CcSEcCtD
Tropicamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00345	0.0037	CcSEcCtD
Tropicamide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00343	0.00367	CcSEcCtD
Tropicamide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00341	0.00365	CcSEcCtD
Tropicamide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00333	0.00357	CcSEcCtD
Tropicamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00332	0.00356	CcSEcCtD
Tropicamide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00332	0.00356	CcSEcCtD
Tropicamide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.0033	0.00353	CcSEcCtD
Tropicamide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.0033	0.00353	CcSEcCtD
Tropicamide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.0033	0.00353	CcSEcCtD
Tropicamide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00328	0.00352	CcSEcCtD
Tropicamide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00328	0.00351	CcSEcCtD
Tropicamide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00328	0.00351	CcSEcCtD
Tropicamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00322	0.00345	CcSEcCtD
Tropicamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00321	0.00344	CcSEcCtD
Tropicamide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00318	0.00341	CcSEcCtD
Tropicamide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00317	0.0034	CcSEcCtD
Tropicamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00317	0.0034	CcSEcCtD
Tropicamide—Headache—Stavudine—acquired immunodeficiency syndrome	0.00316	0.00339	CcSEcCtD
Tropicamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00316	0.00339	CcSEcCtD
Tropicamide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00315	0.00338	CcSEcCtD
Tropicamide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00315	0.00338	CcSEcCtD
Tropicamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00315	0.00337	CcSEcCtD
Tropicamide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00313	0.00335	CcSEcCtD
Tropicamide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00313	0.00335	CcSEcCtD
Tropicamide—Headache—Abacavir—acquired immunodeficiency syndrome	0.00312	0.00334	CcSEcCtD
Tropicamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00311	0.00333	CcSEcCtD
Tropicamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.0031	0.00332	CcSEcCtD
Tropicamide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00303	0.00325	CcSEcCtD
Tropicamide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00303	0.00324	CcSEcCtD
Tropicamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00301	0.00322	CcSEcCtD
Tropicamide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00301	0.00322	CcSEcCtD
Tropicamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.003	0.00321	CcSEcCtD
Tropicamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00295	0.00316	CcSEcCtD
Tropicamide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00294	0.00315	CcSEcCtD
Tropicamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00293	0.00314	CcSEcCtD
Tropicamide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00292	0.00313	CcSEcCtD
Tropicamide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00292	0.00312	CcSEcCtD
Tropicamide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00292	0.00312	CcSEcCtD
Tropicamide—Fenoprofen—ALB—acquired immunodeficiency syndrome	0.00291	0.408	CrCbGaD
Tropicamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00289	0.00309	CcSEcCtD
Tropicamide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00284	0.00304	CcSEcCtD
Tropicamide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00283	0.00303	CcSEcCtD
Tropicamide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00281	0.00301	CcSEcCtD
Tropicamide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00281	0.00301	CcSEcCtD
Tropicamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00279	0.00299	CcSEcCtD
Tropicamide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00278	0.00298	CcSEcCtD
Tropicamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00277	0.00296	CcSEcCtD
Tropicamide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00275	0.00294	CcSEcCtD
Tropicamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00273	0.00292	CcSEcCtD
Tropicamide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00272	0.00291	CcSEcCtD
Tropicamide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.0027	0.00289	CcSEcCtD
Tropicamide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00268	0.00287	CcSEcCtD
Tropicamide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00268	0.00287	CcSEcCtD
Tropicamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00265	0.00283	CcSEcCtD
Tropicamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00261	0.00279	CcSEcCtD
Tropicamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00261	0.00279	CcSEcCtD
Tropicamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00259	0.00278	CcSEcCtD
Tropicamide—Headache—Indinavir—acquired immunodeficiency syndrome	0.00256	0.00274	CcSEcCtD
Tropicamide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00251	0.00269	CcSEcCtD
Tropicamide—Phenprocoumon—ALB—acquired immunodeficiency syndrome	0.00251	0.352	CrCbGaD
Tropicamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00245	0.00263	CcSEcCtD
Tropicamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00245	0.00262	CcSEcCtD
Tropicamide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00242	0.0026	CcSEcCtD
Tropicamide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00242	0.00259	CcSEcCtD
Tropicamide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00242	0.00259	CcSEcCtD
Tropicamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00241	0.00258	CcSEcCtD
Tropicamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00236	0.00252	CcSEcCtD
Tropicamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00235	0.00251	CcSEcCtD
Tropicamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00232	0.00249	CcSEcCtD
Tropicamide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00231	0.00247	CcSEcCtD
Tropicamide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00231	0.00247	CcSEcCtD
Tropicamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00229	0.00245	CcSEcCtD
Tropicamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00225	0.00241	CcSEcCtD
Tropicamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00222	0.00237	CcSEcCtD
Tropicamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00219	0.00235	CcSEcCtD
Tropicamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00217	0.00232	CcSEcCtD
Tropicamide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00214	0.00229	CcSEcCtD
Tropicamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00209	0.00224	CcSEcCtD
Tropicamide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00206	0.0022	CcSEcCtD
Tropicamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00203	0.00217	CcSEcCtD
Tropicamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00199	0.00213	CcSEcCtD
Tropicamide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00196	0.0021	CcSEcCtD
Tropicamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00195	0.00209	CcSEcCtD
Tropicamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00186	0.00199	CcSEcCtD
Tropicamide—Ketoprofen—ALB—acquired immunodeficiency syndrome	0.00172	0.241	CrCbGaD
Tropicamide—CHRM1—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00162	0.0274	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.0014	0.0237	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.00138	0.0234	CbGpPWpGaD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00128	0.0216	CbGpPWpGaD
Tropicamide—CHRM4—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.00122	0.0206	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000973	0.0165	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000862	0.0146	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000859	0.0145	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000851	0.0144	CbGpPWpGaD
Tropicamide—CHRM1—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.00082	0.0139	CbGpPWpGaD
Tropicamide—CHRM3—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.000817	0.0138	CbGpPWpGaD
Tropicamide—CHRM2—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.000809	0.0137	CbGpPWpGaD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000774	0.0131	CbGpPWpGaD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.0007	0.0119	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000656	0.0111	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000654	0.0111	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000648	0.011	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00059	0.00998	CbGpPWpGaD
Tropicamide—CHRM4—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000544	0.00921	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000533	0.00903	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000522	0.00884	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00052	0.00881	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000515	0.00872	CbGpPWpGaD
Tropicamide—CHRM4—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000511	0.00866	CbGpPWpGaD
Tropicamide—CHRM4—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000511	0.00866	CbGpPWpGaD
Tropicamide—CHRM4—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000505	0.00855	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000503	0.00852	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000499	0.00846	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000498	0.00844	CbGpPWpGaD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000478	0.0081	CbGpPWpGaD
Tropicamide—CHRM4—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000475	0.00804	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000472	0.00799	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000471	0.00797	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000466	0.00789	CbGpPWpGaD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000433	0.00732	CbGpPWpGaD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000407	0.00689	CbGpPWpGaD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000407	0.00689	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000398	0.00673	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000396	0.00671	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000392	0.00664	CbGpPWpGaD
Tropicamide—CHRM4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000389	0.00659	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000364	0.00617	CbGpPWpGaD
Tropicamide—CHRM2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000362	0.00613	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000359	0.00609	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000358	0.00607	CbGpPWpGaD
Tropicamide—CHRM2—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000358	0.00606	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000355	0.00601	CbGpPWpGaD
Tropicamide—CHRM4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000351	0.00594	CbGpPWpGaD
Tropicamide—CHRM2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00034	0.00576	CbGpPWpGaD
Tropicamide—CHRM2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00034	0.00576	CbGpPWpGaD
Tropicamide—CHRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00034	0.00576	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000339	0.00575	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000337	0.0057	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000336	0.00569	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000336	0.00568	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000332	0.00563	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000329	0.00558	CbGpPWpGaD
Tropicamide—CHRM4—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000325	0.00551	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000322	0.00546	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000321	0.00544	CbGpPWpGaD
Tropicamide—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00032	0.00542	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000319	0.0054	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000318	0.00539	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000316	0.00535	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00031	0.00524	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00031	0.00524	CbGpPWpGaD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000309	0.00524	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000303	0.00512	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000295	0.00499	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000292	0.00494	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000291	0.00492	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000288	0.00487	CbGpPWpGaD
Tropicamide—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000279	0.00472	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000274	0.00464	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000274	0.00464	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000274	0.00463	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000273	0.00463	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000273	0.00463	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000271	0.00458	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000271	0.00458	CbGpPWpGaD
Tropicamide—CHRM2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000259	0.00439	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000246	0.00416	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000245	0.00414	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000242	0.0041	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000236	0.00399	CbGpPWpGaD
Tropicamide—CHRM2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000233	0.00395	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000222	0.00376	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000221	0.00375	CbGpPWpGaD
Tropicamide—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000219	0.00371	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000219	0.00371	CbGpPWpGaD
Tropicamide—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000219	0.0037	CbGpPWpGaD
Tropicamide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000217	0.00367	CbGpPWpGaD
Tropicamide—CHRM4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000212	0.00359	CbGpPWpGaD
Tropicamide—CHRM3—Metabolism—TAT—acquired immunodeficiency syndrome	0.000211	0.00358	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000209	0.00354	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000209	0.00354	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000209	0.00353	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000208	0.00352	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000208	0.00352	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000208	0.00352	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000206	0.00349	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000206	0.00349	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000206	0.00349	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000204	0.00345	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000203	0.00344	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000201	0.00341	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000199	0.00337	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000198	0.00336	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000196	0.00332	CbGpPWpGaD
Tropicamide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000188	0.00318	CbGpPWpGaD
Tropicamide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000187	0.00317	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000187	0.00316	CbGpPWpGaD
Tropicamide—CHRM4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000186	0.00315	CbGpPWpGaD
Tropicamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000186	0.00314	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000184	0.00312	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000184	0.00311	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000182	0.00308	CbGpPWpGaD
Tropicamide—CHRM3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00018	0.00304	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000179	0.00303	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000179	0.00303	CbGpPWpGaD
Tropicamide—CHRM4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000175	0.00296	CbGpPWpGaD
Tropicamide—CHRM4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000175	0.00296	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000169	0.00286	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000162	0.00274	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000159	0.00269	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000159	0.00269	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000159	0.00269	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000158	0.00268	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000157	0.00266	CbGpPWpGaD
Tropicamide—CHRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000143	0.00242	CbGpPWpGaD
Tropicamide—CHRM3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000143	0.00242	CbGpPWpGaD
Tropicamide—CHRM2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000141	0.00239	CbGpPWpGaD
Tropicamide—CHRM2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000136	0.00231	CbGpPWpGaD
Tropicamide—CHRM4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000133	0.00225	CbGpPWpGaD
Tropicamide—CHRM4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000131	0.00222	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000126	0.00213	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000126	0.00213	CbGpPWpGaD
Tropicamide—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000126	0.00213	CbGpPWpGaD
Tropicamide—CHRM3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000125	0.00212	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000124	0.00211	CbGpPWpGaD
Tropicamide—CHRM2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000124	0.0021	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000121	0.00205	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000121	0.00204	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000121	0.00204	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00012	0.00203	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00012	0.00203	CbGpPWpGaD
Tropicamide—CHRM4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00012	0.00203	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000119	0.00202	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000119	0.00201	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000119	0.00201	CbGpPWpGaD
Tropicamide—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000118	0.002	CbGpPWpGaD
Tropicamide—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000118	0.002	CbGpPWpGaD
Tropicamide—CHRM3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000118	0.00199	CbGpPWpGaD
Tropicamide—CHRM3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000118	0.00199	CbGpPWpGaD
Tropicamide—CHRM2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000116	0.00197	CbGpPWpGaD
Tropicamide—CHRM2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000116	0.00197	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000114	0.00193	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000114	0.00192	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000113	0.00191	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00011	0.00187	CbGpPWpGaD
Tropicamide—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.00011	0.00186	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000109	0.00185	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000109	0.00184	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000109	0.00184	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000108	0.00182	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000107	0.00181	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000107	0.00181	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000107	0.00181	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000107	0.00181	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000106	0.00179	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000106	0.00179	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.99e-05	0.00169	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.39e-05	0.00159	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.39e-05	0.00159	CbGpPWpGaD
Tropicamide—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	9.1e-05	0.00154	CbGpPWpGaD
Tropicamide—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.98e-05	0.00152	CbGpPWpGaD
Tropicamide—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.95e-05	0.00152	CbGpPWpGaD
Tropicamide—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.86e-05	0.0015	CbGpPWpGaD
Tropicamide—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.84e-05	0.0015	CbGpPWpGaD
Tropicamide—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.81e-05	0.00149	CbGpPWpGaD
Tropicamide—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.73e-05	0.00148	CbGpPWpGaD
Tropicamide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	8.62e-05	0.00146	CbGpPWpGaD
Tropicamide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	8.59e-05	0.00145	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.15e-05	0.00138	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.13e-05	0.00138	CbGpPWpGaD
Tropicamide—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.09e-05	0.00137	CbGpPWpGaD
Tropicamide—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.06e-05	0.00137	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.05e-05	0.00136	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.03e-05	0.00136	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8e-05	0.00136	CbGpPWpGaD
Tropicamide—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.98e-05	0.00135	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.93e-05	0.00134	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.44e-05	0.00126	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.42e-05	0.00126	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.35e-05	0.00124	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.34e-05	0.00124	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.32e-05	0.00124	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.25e-05	0.00123	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.14e-05	0.00121	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.04e-05	0.00119	CbGpPWpGaD
Tropicamide—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.93e-05	0.00117	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.73e-05	0.00114	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.71e-05	0.00114	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.65e-05	0.00113	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.43e-05	0.00109	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.33e-05	0.00107	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.33e-05	0.00107	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.31e-05	0.00107	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.31e-05	0.00107	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.29e-05	0.00107	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.25e-05	0.00106	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.25e-05	0.00106	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.82e-05	0.000815	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.8e-05	0.000813	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.75e-05	0.000805	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.74e-05	0.000803	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.73e-05	0.000801	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.68e-05	0.000793	CbGpPWpGaD
Tropicamide—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.67e-05	0.000791	CbGpPWpGaD
Tropicamide—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.66e-05	0.000789	CbGpPWpGaD
Tropicamide—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.61e-05	0.000781	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.34e-05	0.000735	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.32e-05	0.000732	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.28e-05	0.000725	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.24e-05	0.000719	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.23e-05	0.000716	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.19e-05	0.000709	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.72e-05	0.000629	CbGpPWpGaD
Tropicamide—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.7e-05	0.000626	CbGpPWpGaD
Tropicamide—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	3.69e-05	0.000624	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.51e-05	0.000424	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.5e-05	0.000423	CbGpPWpGaD
Tropicamide—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.49e-05	0.000422	CbGpPWpGaD
Tropicamide—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.49e-05	0.000421	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.47e-05	0.000419	CbGpPWpGaD
Tropicamide—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.46e-05	0.000417	CbGpPWpGaD
Tropicamide—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.19e-05	0.00037	CbGpPWpGaD
Tropicamide—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.47e-05	0.000249	CbGpPWpGaD
Tropicamide—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.47e-05	0.000249	CbGpPWpGaD
Tropicamide—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.45e-05	0.000246	CbGpPWpGaD
